跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 595 条关于
“Hainan Herui”
全部
595
临床试验
371
药物
73
机构
93
资讯
58
2个月前
Everest Medicines and Hainan Herui Forge Commercialization Partnership for Budesonide Enteric Capsules in China
5个月前
Hainan's Boao Lecheng Pilot Zone Slashes Drug Approval to 1.6 Days, Transforming Rare Disease Access
3个月前
Immunotech-B Targets 39-Month Timeline for EAL Resubmission in Liver Cancer, Advances ATL Cell Therapy Commercialization
28天前
China's Personalized mRNA Cancer Therapy Sector Accelerates as LK101 Advances Toward Clinical Validation
7个月前
China's NMPA Accepts Review of Ohtuvayre for COPD Maintenance Treatment
去年
Changchun High-Tech Secures €177.7 Million Deal for ALK's House Dust Mite Allergy Immunotherapies in China
去年
Nuance Pharma's Ohtuvayre Receives First Approval Outside US for COPD Treatment in Macau
去年
Sanofi's Tzield Debuts in China as First FDA-Approved Therapy to Delay Type 1 Diabetes Onset
3个月前
Nuance Pharma Receives NMPA Clearance for Actair® Phase III Trial in China
去年
Ruxolitinib Cream Prescriptions for Vitiligo Issued in Greater Bay Area, China; NDA Accepted by NMPA
第 1 页,共 6 页
上一页
下一页